Table 4.
Covariate | 1.5T | 3T | ||
---|---|---|---|---|
Spearman’s rho | p-value | Spearman’s rho | p-value | |
Mean baseline liver PDFF | 0.81 | <0.001* | 0.73 | <0.001 |
Age | −0.14 | 0.20 | −0.09 | 0.35 |
Gender | NA | 0.08 | NA | 0.41 |
Weight | −0.11 | 0.30 | −0.12 | 0.21 |
BMI Z-score | 0.12 | 0.27 | 0.04 | 0.64 |
Systolic blood pressure | 0.002 | 0.98 | 0.02 | 0.85 |
Diastolic blood pressure | 0.01 | 0.92 | 0.11 | 0.24 |
Platelet count | 0.05 | 0.67 | 0.07 | 0.44 |
Glycosylated hemoglobin | −0.07 | 0.52 | −0.06 | 0.49 |
Aspartate aminotransferase | 0.09 | 0.39 | 0.11 | 0.25 |
Alanine aminotransferase | 0.25 | <0.02* | 0.17 | 0.07 |
Gamma-glutamyl transferase | 0.01 | 0.91 | 0.10 | 0.29 |
Total bilirubin | 0.04 | 0.71 | −0.05 | 0.61 |
Serum triglycerides | 0.07 | 0.49 | 0.15 | 0.10 |
Total cholesterol | 0.06 | 0.57 | 0.14 | 0.15 |
Fasting blood glucose | 0.10 | 0.36 | −0.02 | 0.85 |
Insulin | −0.11 | 0.32 | 0.01 | 0.89 |
Log-transformed ferritin | 0.32 | <0.005* | 0.23 | <0.02* |
Steatosis grade | 0.57 | <0.001* | 0.53 | <0.001* |
Steatosis location (acinar) | NA | 0.44 | NA | 0.33 |
Steatosis location (azonal/periportal) | NA | <0.05* | NA | <0.05* |
Steatosis location (panacinar) | NA | <0.05* | NA | <0.01* |
Hepatocyte ballooning score | −0.17 | 0.11 | −0.26 | <0.01* |
Lobular inflammation score | −0.18 | 0.09 | 0.11 | 0.23 |
Portal inflammation score | −0.11 | 0.29 | 0.08 | 0.40 |
NAFLD activity score | 0.14 | 0.19 | 0.18 | <0.05* |
Fibrosis stage | −0.18 | 0.09 | −0.05 | 0.57 |
Lipid droplet size | NA | 0.57 | NA | <0.001 |
Glycogenosis | 0.02 | 0.88 | −0.02 | 0.87 |
Hepatocellular iron grade | NA | 0.13 | NA | 0.10 |
Non-hepatocellular iron grade | NA | 0.20 | NA | 0.05 |
Statistically significant, without correction for multiple comparisons